Sun Pharmaceutical Industries launches novel formulation in cough management ‘Chericof 12’
28th Sep 2021

Sun Pharmaceutical Industries and includes its subsidiaries and/or associate companies) have launched novel formulation in cough management - Chericof 12 (Dextromethorphan Hydrobromide 30 mg and Chlorpheniramine Maleate 4 mg) in India. Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug. Chericof 12 is approved for patients of age group six years and above.

All cough syrups generally give relief for 6-8 hours, and hence a patient has to take it three to four times a day. Frequent dosing often leads to patient inconvenience and non-adherence to follow the regimen, which may compromise the efficacy of the medication and disturb the daily lifestyle.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.